NEW YORK, NY--(Marketwired - Aug 21, 2014) - Wall Street Analyzer's CEO Interview Series
BiOasis (OTCQX: BIOAF) (TSX VENTURE: BTI) released positive quantitative results regarding their newly developed carrier peptide Transcendpep which effectively delivers siRNA across the BBB (blood-brain barrier) into brain cells. The Company recently entered into a license agreement with Medimmune for a second-generation version of BiOasis's Transcend. CEO Rob Hutchison shed some light on the recent developments and discussed the importance of the company's OTCQX listing from earlier this year.
NioCorp Developments Ltd. (OTCQX: NIOBF) (TSX VENTURE: NB) released high-grade assay results and a metallurgical update on the company's Elk Creek project in Nebraska. CEO Mark Smith took time to discuss this flagship project at length. In addition, he talked about recent trends in the Niobium market as the company looks to fill a need for the steel, automotive, and aviation industries. Mr. Smith also provided insight into NioCorp's key technical team.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as SLWF or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, such statements in this release that describe the company's business strategy, outlook, objectives, plans, intentions, or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. These risks and uncertainties include, among other things, product price volatility, product demand, market competition, and risk inherent in the operations of a company. We assume no obligation to update any written or oral forward-looking statement made by us or on our behalf as a result of new information, future events or other factors.
Für den Inhalt des Beitrages ist allein der Autor verantwortlich bzw. die aufgeführte Quelle. Bild- oder Filmrechte liegen beim Autor/Quelle bzw. bei der vom ihm benannten Quelle. Bei Übersetzungen können Fehler nicht ausgeschlossen werden. Der vertretene Standpunkt eines Autors spiegelt generell nicht die Meinung des Webseiten-Betreibers wieder. Mittels der Veröffentlichung will dieser lediglich ein pluralistisches Meinungsbild darstellen. Direkte oder indirekte Aussagen in einem Beitrag stellen keinerlei Aufforderung zum Kauf-/Verkauf von Wertpapieren dar. Wir wehren uns gegen jede Form von Hass, Diskriminierung und Verletzung der Menschenwürde. Beachten Sie bitte auch unsere AGB/Disclaimer!
